T. Filleron

发表

Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer

B. Asselain, J. Pierga, L. Belin, 2016, Breast Cancer Research and Treatment.

The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients

T. Brodowicz, N. Penel, J. Boher, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Statistical controversies in clinical research: should schedules of tumor size assessments be changed?

A. Duhamel, F. Joly, N. Houédé, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment

T. Valentin, S. Le Guellec, C. Chevreau, 2021, Strahlentherapie und Onkologie.

The STEMRI trial: magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma-initiating cells

C. Toulas, T. Filleron, V. Lubrano, 2023, medRxiv.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S. Sleijfer, F. Collin, M. van Glabbeke, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Pseudoprogression versus true progression in patients with glioblastoma: A multiapproach analysis.

P. Péran, F. Tensaouti, J. Lotterie, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Detection of local recurrences of limb soft-tissue sarcomas: Is magnetic resonance imaging (MRI) relevant?

T. Filleron, T. Filleron, C. Chevreau, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

260P Antitumor activity of trastuzumab deruxtecan (T-DXd) in patients with metastatic breast cancer (mBC) and brain metastases (BMs) from DAISY trial

J. Pierga, X. Durando, V. Diéras, 2022, Annals of Oncology.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

H. Wildiers, J. Bogaerts, J. Yarnold, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

846P Triple combination of ipilimumab + nivolumab + anti-TNF in treatment naive melanoma patients: Final analysis of TICIMEL, a phase Ib prospective clinical trial

N. Meyer, A. Montfort, T. Filleron, 2022, Annals of Oncology.